Skip to content
lifestyle.infotechinc.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
4Bio Capital
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
September 29, 2026
4BIO Capital Leads $33M Seed for Cloverleaf Bio’s RNA Cancer Therapeutics
September 8, 2026
4BIO Capital leads oversubscribed £61 million ($83m) Series A financing of Cytospire Therapeutics
May 23, 2026
4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments
April 21, 2026